Bruker (BRKR) Cash from Financing Activities (2010 - 2026)

Bruker has reported Cash from Financing Activities for 17 years, with the latest figure at -$204.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 300.2% year-over-year to -$204.9 million; the trailing twelve-month figure through Mar 2026 stood at -$18.6 million (down 101.81% YoY), and the FY2025 full-year result was $135.1 million, down 89.01% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$204.9 million, down from -$167.6 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $1.2 billion in Q2 2024, with the low at -$217.4 million in Q1 2022.
• Historically, Cash from Financing Activities has averaged $32.4 million across 5 years, with a median of -$51.2 million in 2025.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 3053.85% — and 2024, when it jumped 11321.36%.
• Bruker's Cash from Financing Activities stood at -$36.1 million in 2022, then tumbled by 65.93% to -$59.9 million in 2023, then decreased by 25.21% to -$75.0 million in 2024, then tumbled by 123.47% to -$167.6 million in 2025, then slipped by 22.26% to -$204.9 million in 2026.
• The last three Cash from Financing Activities figures came in at -$204.9 million (Q1 2026), -$167.6 million (Q4 2025), and $258.4 million (Q3 2025), per Business Quant data.